# generated on  2016-01-19T14:51:04.814-06:00

@prefix Contraindication <http://hl7.org/fhir> .
@prefix fhir: <http://hl7.org/fhir/> .
@prefix xhtml: <http://www.w3.org/1999/xhtml> .
@prefix xsd: <http://www.w3.org/2001/XMLSchema> .
@base <http://this-fhir-server/fhir/> .

[] a fhir:Contraindication;
   fhir:Contraindication.id [ fhir:value "ddi" ];
   fhir:Contraindication.text [ 
      a fhir:Narrative;
      fhir:Narrative.status [ fhir:value "generated" ];
      fhir:Narrative.div [ 
         a fhir:xhtml;
         fhir:text [ fhir:value """<div><p><b>Severity: High</b> - Risk of internal bleeding
      </p><p>Those who take acetaminophen along with the widely used blood-thinning drug warfarin may face the risk of serious internal bleeding. People on warfarin who take acetaminophen for at least seven days in a row should be closely watched for bleeding.</p><ul><li><a href="MedicationStatement/tylenol">500 mg Acetaminophen tablet 1/day, PRN since 2010</a></li><li><a href="MedicationPrescription/warfarin">Warfarin 1 MG TAB prescribed Jan. 5, 2014</a></li></ul><p>Mitigation: Jan 5, 2014 by Dr. Adam Careful: </p><p>Asked patient to discontinue regular use of Tylenol and to consult with clinician if they need to resume to allow appropriate INR monitoring</p></div>""" ]       ]
    ];
   fhir:Contraindication.category [ 
      a fhir:CodeableConcept;
      fhir:CodeableConcept.coding [ 
         a fhir:Coding;
         fhir:Coding.system [ fhir:value "http://hl7.org/fhir/v3/ActCode" ];
         fhir:Coding.code [ fhir:value "DRG" ];
         fhir:Coding.display [ fhir:value "Drug Interaction Alert" ];
       ];
    ];
   fhir:Contraindication.severity [ fhir:value "H" ];
   fhir:Contraindication.implicated <MedicationStatement/tylenol>;
;
   fhir:Contraindication.implicated <MedicationPrescription/warfarin>;
;
   fhir:Contraindication.detail [ fhir:value "Risk of internal bleeding.  Those who take acetaminophen along with the widely used blood-thinning drug warfarin may face the risk of serious internal bleeding. People on warfarin who take acetaminophen for at least seven days in a row should be closely watched for bleeding." ];
   fhir:Contraindication.date [ fhir:value "2014-01-05" ];
   fhir:Contraindication.author <Device/dsp>;
;
   fhir:Contraindication.author_1 <Device/dsp>;
;
   fhir:Contraindication.mitigation [ 
      a fhir:Contraindication.mitigation;
      fhir:Contraindication.mitigation.action [ 
         a fhir:CodeableConcept;
         fhir:CodeableConcept.coding [ 
            a fhir:Coding;
            fhir:Coding.system [ fhir:value "http://hl7.org/fhir/v3/ActCode" ];
            fhir:Coding.code [ fhir:value "30" ];
            fhir:Coding.display [ fhir:value "Stopped Concurrent Therapy" ];
          ];
         fhir:CodeableConcept.text [ fhir:value "Asked patient to discontinue regular use of Tylenol and to consult with clinician if they need to resume to allow appropriate INR monitoring" ]
       ];
      fhir:Contraindication.mitigation.date [ fhir:value "2014-01-05" ];
      fhir:Contraindication.mitigation.author <Practitioner/example>

    ]
 .
<MedicationStatement/tylenol> fhir:Reference.display [ fhir:value "500 mg Acetaminophen tablet 1/day, PRN since 2010" ] .
<MedicationPrescription/warfarin> fhir:Reference.display [ fhir:value "Warfarin 1 MG TAB prescribed Jan. 5, 2014" ] .
<Practitioner/example> fhir:Reference.display [ fhir:value "Dr. Adam Careful" ] .
